People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Other Technology, Software / Tech, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cogito Corp | — | Other Technology | Series C | $159.1M | $865.6M | 2015 |
| Placester, Inc. | — | Other Technology | Series C | $93.5M | $1.6B | 2015 |
| Allurion Technologies, Inc. | — | Software / Tech | Series B | $36.1M | $23.1M | 2025 |
| Presto Phoenix, Inc. | — | Other Technology | Series B | $28.0M | $44.4M | 2024 |
| Ceres Imaging, Inc. | — | Other | Series B | $25.3M | $194.9M | 2023 |
| Vyome Therapeutics Inc. | — | Pharmaceuticals | Series A | $14.5M | $351.1M | 2018 |
| Presto Automation Inc. | — | Other Technology | Series A | $9.5M | $82.0M | 2023 |
| Cohealo Inc. | — | Other Technology | Seed | $5.0M | $50.0M | 2018 |
| Padloc Inc. | — | Other Technology | Pre-Seed | $1.0M | $42.4M | 2015 |
Krishna Gupta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Krishna Gupta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Anderson | 1 | 21 |
| Chetan Puttagunta | 1 | 12 |
| Scott Maxwell | 1 | 11 |
| David Klein | 1 | 10 |
| Ravi Viswanathan | 1 | 9 |
| Chris Garabedian | 1 | 8 |
| Hemant Shah | 1 | 6 |
| Keith Kravcik | 1 | 4 |
| Ilya Golubovich | 1 | 4 |
| Mark Midle | 1 | 3 |
| Susan Carstensen | 1 | 3 |
| Mohanjit Jolly | 1 | 3 |
| Larson Douglas Hudson | 1 | 3 |
| Lillian Meyer | 1 | 2 |
| Gail Zauder | 1 | 2 |
| Frederick Townes | 1 | 2 |
| Paul Lisiak | 1 | 2 |
| Stanley Mbugua | 1 | 2 |
| Alex Pentland | 1 | 2 |
| Omar Ishrak | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.